101 related articles for article (PubMed ID: 7779646)
1. Gastrointestinal side-effects of NSAIDs in the community.
Jones RH; Tait CL
Br J Clin Pract; 1995; 49(2):67-70. PubMed ID: 7779646
[TBL] [Abstract][Full Text] [Related]
2. Valdecoxib is associated with improved dyspepsia-related health compared with nonspecific NSAIDs in patients with osteoarthritis or rheumatoid arthritis.
Rabeneck L; Goldstein JL; Vu A; Mayne TJ; Rublee DA
Am J Gastroenterol; 2005 May; 100(5):1043-50. PubMed ID: 15842577
[TBL] [Abstract][Full Text] [Related]
3. NSAID-associated dyspepsia and ulcers: a prospective cohort study in primary care.
Hollenz M; Stolte M; Leodolter A; Labenz J
Dig Dis; 2006; 24(1-2):189-94. PubMed ID: 16699277
[TBL] [Abstract][Full Text] [Related]
4. Underutilization of preventive strategies in patients receiving NSAIDs.
Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
[TBL] [Abstract][Full Text] [Related]
5. Long-term NSAID use in primary care: changes over a decade and NICE risk factors for gastrointestinal adverse events.
Thompson PW; Tee L; McBride J; Quincey D; Strat Liddiard G
Rheumatology (Oxford); 2005 Oct; 44(10):1308-10. PubMed ID: 15972345
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of dyspepsia and nonsteroidal antiinflammatory drugs.
Ofman JJ; Maclean CH; Straus WL; Morton SC; Berger ML; Roth EA; Shekelle PG
Arthritis Rheum; 2003 Aug; 49(4):508-18. PubMed ID: 12910557
[TBL] [Abstract][Full Text] [Related]
7. Over-the-counter nonsteroidal anti-inflammatory drugs and risk of gastrointestinal symptoms.
Thomas J; Straus WL; Bloom BS
Am J Gastroenterol; 2002 Sep; 97(9):2215-9. PubMed ID: 12358235
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal complications of over-the-counter nonsteroidal antiinflammatory drugs.
Biskupiak JE; Brixner DI; Howard K; Oderda GM
J Pain Palliat Care Pharmacother; 2006; 20(3):7-14. PubMed ID: 16931473
[TBL] [Abstract][Full Text] [Related]
9. Nonsteroidal anti-inflammatory drug use as a risk factor for gastro-oesophageal reflux disease: an observational study.
Ruszniewski P; Soufflet C; Barthélémy P
Aliment Pharmacol Ther; 2008 Nov; 28(9):1134-9. PubMed ID: 18671778
[TBL] [Abstract][Full Text] [Related]
10. The use and safety profile of non-steroidal antiinflammatory drugs among Turkish patients with osteoarthritis.
Yilmaz H; Gürel S; Ozdemir O
Turk J Gastroenterol; 2005 Sep; 16(3):138-42. PubMed ID: 16245223
[TBL] [Abstract][Full Text] [Related]
11. [Nonvariceal upper gastrointestinal hemorrhage associated with nonsteroidal anti-inflammatory drugs in Metropolitan Lima].
Salvatierra Laytén G; de la Cruz Romero L; Paulino Merino M; Vidal Vidal V; Rivera Dávila C; Cano Chuquilin A; Frisancho Velarde O
Rev Gastroenterol Peru; 2006; 26(1):13-20. PubMed ID: 16622483
[TBL] [Abstract][Full Text] [Related]
12. Striking prevalence of over-the-counter nonsteroidal anti-inflammatory drug use in patients with upper gastrointestinal hemorrhage.
Wilcox CM; Shalek KA; Cotsonis G
Arch Intern Med; 1994 Jan; 154(1):42-6. PubMed ID: 8267488
[TBL] [Abstract][Full Text] [Related]
13. Prescription of nonsteroidal anti-inflammatory drugs for elderly people in Alberta.
Hogan DB; Campbell NR; Crutcher R; Jennett P; MacLeod N
CMAJ; 1994 Aug; 151(3):315-22. PubMed ID: 8039085
[TBL] [Abstract][Full Text] [Related]
14. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
[TBL] [Abstract][Full Text] [Related]
15. Does the varied use of NSAIDs explain the differences in the risk of myocardial infarction?
van Staa TP; Rietbrock S; Setakis E; Leufkens HG
J Intern Med; 2008 Nov; 264(5):481-92. PubMed ID: 18624902
[TBL] [Abstract][Full Text] [Related]
16. A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure.
Pope JE; Anderson JJ; Felson DT
Arch Intern Med; 1993 Feb; 153(4):477-84. PubMed ID: 8435027
[TBL] [Abstract][Full Text] [Related]
17. The role of proton pump inhibitors in NSAID-associated gastropathy and upper gastrointestinal symptoms.
Laine L
Rev Gastroenterol Disord; 2003; 3 Suppl 4():S30-9. PubMed ID: 14671512
[TBL] [Abstract][Full Text] [Related]
18. [The lack of awareness of the Israeli population regarding gastrointestinal complications from non-steroidal anti-inflammatory drugs].
Zandman-Goddard G; Langevitz P
Harefuah; 2001 Jun; 140(6):476-8, 567, 566. PubMed ID: 11420844
[TBL] [Abstract][Full Text] [Related]
19. Incidence of outpatient physician claims for upper gastrointestinal symptoms among new users of celecoxib, ibuprofen, and naproxen in an insured population in the United States.
Goldstein JL; Zhao SZ; Burke TA; Palmer R; von Allmen H; Henderson SC
Am J Gastroenterol; 2003 Dec; 98(12):2627-34. PubMed ID: 14687808
[TBL] [Abstract][Full Text] [Related]
20. NSAID-induced gastrointestinal damage: current clinical management and recommendations for prevention.
Lanas A; Ferrandez A
Chin J Dig Dis; 2006; 7(3):127-33. PubMed ID: 16808792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
